Atrey Pharmaceuticals Private Limited, a active private limited company, was established on 26 April 2013 in Ahmedabad, Gujarat, India. Engaging in cosmetics & makeup products within the trade sector, it holds CIN: U24100GJ2013PTC074736. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.90 M and a paid-up capital of ₹2.90 M.
Formerly known as Coscare India Private Limited. It upholds a compliant status. Its leadership includes Minish Shantilal Shah (Director), Naman Minish Shah (Director). Past directors included Shah Minish Hina, Shantanu Minish Shah, Stuti Naman Shah. It holds ₹2.88 Cr open charges and no settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Paldi Kankaj, Ahmedabad, Gujarat, 382425.
U24100GJ2013PTC074736
074736
26 April 2013
₹2.90 M
₹2.90 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Atrey Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Minish Shantilal Shah | Director | 26 Apr 2013 | Current |
| Naman Minish Shah | Director | 26 Apr 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jun 2021 | Past |
| Pramod Abcsdd | Director | 20 May 2021 | Past |
| Pramod Abcsdd | Director | 07 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Atrey Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.56% increase. The company also saw a substantial improvement in profitability, with a 15.99% increase in profit. The company's net worth dipped by a decrease of 1.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Atrey Pharmaceuticals had a public holding of 45.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹28,786,900.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2022 | Sidbi | ₹1.77 M | Open |
| 18 Aug 2020 | Sidbi | ₹3.53 M | Open |
| 17 Apr 2020 | Sidbi | ₹1.19 M | Open |
| 26 Jun 2019 | Sidbi | ₹1.80 M | Open |
| 29 Jan 2018 | Sidbi | ₹8.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Atrey Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Atrey Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atrey Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Atrey Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Atrey Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
A charge with Sidbi amounted to Rs. 1.77 M with Charge ID 100546383 was registered on 15 Mar 2022. was recorded as a recent event.
Progress on A charge with Sidbi of Rs. 3.53 M registered on 18 Aug 2020 with Charge ID 100367192 was modified on 21 Aug 2020. was documented.
The activity A charge with Sidbi of Rs. 1.19 M registered on 17 Apr 2020 with Charge ID 100362893 was modified on 21 Aug 2020. was completed.
Progress on A charge with Sidbi amounted to Rs. 3.53 M with Charge ID 100367192 was registered on 18 Aug 2020. was documented.
The CIN of Atrey Pharmaceuticals Private Limited is U24100GJ2013PTC074736.
Atrey Pharmaceuticals Private Limited is headquartered at Paldi Kankaj, Ahmedabad, Gujarat, 382425.
Atrey Pharmaceuticals Private Limited was incorporated on 26 April 2013.
The current directors of Atrey Pharmaceuticals Private Limited are
The primary industry of Atrey Pharmaceuticals Private Limited is Trade.
Atrey Pharmaceuticals Private Limited is unlisted.
The authorized capital of Atrey Pharmaceuticals Private Limited is ₹2.90 M, and the paid-up capital is ₹2.90 M.
The compliance status of Atrey Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX